Literature DB >> 26583760

MR Imaging of Brachial Plexus and Limb-Girdle Muscles in Patients with Amyotrophic Lateral Sclerosis.

Simonetta Gerevini1, Federica Agosta1, Nilo Riva1, Edoardo G Spinelli1, Elisabetta Pagani1, Giandomenico Caliendo1, Linda Chaabane1, Massimiliano Copetti1, Angelo Quattrini1, Giancarlo Comi1, Andrea Falini1, Massimo Filippi1.   

Abstract

PURPOSE: To assess brachial plexus magnetic resonance (MR) imaging features and limb-girdle muscle abnormalities as signs of muscle denervation in patients with amyotrophic lateral sclerosis (ALS).
MATERIALS AND METHODS: This study was approved by the local ethical committees on human studies, and written informed consent was obtained from all subjects before enrollment. By using an optimized protocol of brachial plexus MR imaging, brachial plexus and limb-girdle muscle abnormalities were evaluated in 23 patients with ALS and clinical and neurophysiologically active involvement of the upper limbs and were compared with MR images in 12 age-matched healthy individuals. Nerve root and limb-girdle muscle abnormalities were visually evaluated by two experienced observers. A region of interest-based analysis was performed to measure nerve root volume and T2 signal intensity. Measures obtained at visual inspection were analyzed by using the Wald χ(2) test. Mean T2 signal intensity and volume values of the regions of interest were compared between groups by using a hierarchical linear model, accounting for the repeated measurement design.
RESULTS: The level of interrater agreement was very strong (κ = 0.77-1). T2 hyperintensity and volume alterations of C5, C6, and C7 nerve roots were observed in patients with ALS (P < .001 to .03). Increased T2 signal intensity of nerve roots was associated with faster disease progression (upper-limb Medical Research Council scale progression rate, r = 0.40; 95% confidence interval: 0.001, 0.73). Limb-girdle muscle alterations (ie, T2 signal intensity alteration, edema, atrophy) and fat infiltration also were found, in particular, in the supraspinatus muscle, showing more frequent T2 signal intensity alterations and edema (P = .01) relative to the subscapularis and infraspinatus muscles.
CONCLUSION: Increased T2 signal intensity and volume of brachial nerve roots do not exclude a diagnosis of ALS and suggest involvement of the peripheral nervous system in the ALS pathogenetic cascade. MR imaging of the peripheral nervous system and the limb-girdle muscle may be useful for monitoring the evolution of ALS and distinguishing patients with ALS from those with inflammatory neuropathy, respectively. (©) RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26583760     DOI: 10.1148/radiol.2015150559

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS.

Authors:  Neil G Simon; Jim Lagopoulos; Sita Paling; Casey Pfluger; Susanna B Park; James Howells; Thomas Gallagher; Michel Kliot; Robert D Henderson; Steve Vucic; Matthew C Kiernan
Journal:  J Neurol       Date:  2017-03-06       Impact factor: 4.849

2.  Improved Brachial Plexus Visualization Using an Adiabatic iMSDE-Prepared STIR 3D TSE.

Authors:  Elisabeth Klupp; Barbara Cervantes; Nico Sollmann; Franziska Treibel; Dominik Weidlich; Thomas Baum; Ernst J Rummeny; Claus Zimmer; Jan S Kirschke; Dimitrios C Karampinos
Journal:  Clin Neuroradiol       Date:  2018-07-23       Impact factor: 3.649

3.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

4.  Magnetic resonance imaging evaluation of masticatory muscle changes in patients with primary trigeminal neuralgia before microvascular decompression.

Authors:  Xiaojuan Zhang; Chuandong Wang; Dan Zheng; Hui Xiao; Qun Zhong
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

5.  Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy.

Authors:  Matteo Lucchini; Sara Bortolani; Mauro Monforte; Manuela Papacci; Enzo Ricci; Massimiliano Mirabella; Giorgio Tasca
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-19

6.  Imaging muscle as a potential biomarker of denervation in motor neuron disease.

Authors:  Thomas M Jenkins; James J P Alix; Charlotte David; Eilish Pearson; D Ganesh Rao; Nigel Hoggard; Eoghan O'Brien; Kathleen Baster; Michael Bradburn; Julia Bigley; Christopher J McDermott; Iain D Wilkinson; Pamela J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-10-31       Impact factor: 10.154

Review 7.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

8.  Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative.

Authors:  Matthew C Evans; Charles Wade; David Hohenschurz-Schmidt; Pete Lally; Albert Ugwudike; Kamal Shah; Neal Bangerter; David J Sharp; Andrew S C Rice
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

9.  Longitudinal Quantitative MRI Evaluation of Muscle Involvement in Amyotrophic Lateral Sclerosis.

Authors:  Matteo Paoletti; Luca Diamanti; Shaun I Muzic; Elena Ballante; Francesca Solazzo; Lia Foppoli; Xeni Deligianni; Francesco Santini; Silvia Figini; Niels Bergsland; Anna Pichiecchio
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

10.  Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease.

Authors:  Thomas M Jenkins; James J P Alix; Jacob Fingret; Taniya Esmail; Nigel Hoggard; Kathleen Baster; Christopher J McDermott; Iain D Wilkinson; Pamela J Shaw
Journal:  J Neurol       Date:  2019-10-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.